Activity Description

Cystic Fibrosis (CF) is an inherited chronic disease caused by a gene defect. It
is estimated to occur in about 1 in every 3500 children born in the United States.
This complex disease can affect the lungs, the digestive system, and other organs
resulting in a high morbidity and mortality. CF can also affect the pharmacokinetics
of many drugs and this needs to be considered when prescribing medications to CF patients.
CF has no known cure, but treatments are available to help modify the disease process.
The modules of this program will provide information on the disease and treatments
for the CF patient as well as address other important challenges and considerations
in CF patients. Module 4 discusses the importance of adherence in CF patients
and will address the role of education to improve the treatment of CF patients.

Learning Objectives

The target audience for this activity includes pharmacists. Upon completion
of this activity, participants will be able to:

Define adherence

Describe the medication access programs available for CF patients

Discuss the role of education in improving medication adherence in CF patients

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and
scientific rigor in all of its continuing education activities. Faculty must disclose
to participants the existence of any significant financial interest or any other relationship
with the manufacturer of any commercial product(s) discussed in an educational presentation.
David Young does not have any relevant commercial and/or financial relationships
to disclose.

Please note: The opinions expressed in this activity should not be construed as
those of the CME/CE provider. The information and views are those of the faculty through
clinical practice and knowledge of the professional literature. Portions of this activity
may include unlabeled indications. Use of drugs and devices outside of labeling should
be considered experimental and participants are advised to consult prescribing information
and professional literature.

CE Accreditation

Release Date: 02-13-2017
Expiration Date: 02-13-2020

Pharmacists

This CE activity is jointly provided by ProCE, Inc. and the National
Association of Specialty Pharmacy (NASP). ProCE is accredited by the Accreditation
Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE
Universal Activity Number 0221-9999-19-081-H01-P has been assigned to this knowledge-based,
home-study activity. This CE activity is approved for 1.0 contact hour (0.1 CEU)
in states that recognize ACPE providers. Completion of an evaluation and post-test
with a score of 70% or higher is required to receive CE credit. Proof of completion
will be posted in NABP CPE Monitor profiles. No partial credit will be given.

Funding

No external support has been received for this activity.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.